The value of p53 protein expression in gallbladder carcinoma: Analysis of 60 cases

Hepato-Gastroenterology

Volumn 51, Issue 59, 2004, Pages 1310-1314

  Da Rocha, Andréa Oxley ^a,b   Coutinho, Lígia Maria Barbosa ^a   Scholl, João Grigoletti ^a   Leboutte, Laĩs Dal'Pino ^a  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^b NONE   (Brazil)

Author keywords

Gallbladder; Gallbladder cancer; Immunohistochemical; p53

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; CANCER SURVIVAL; CHOLELITHIASIS; CHRONIC CHOLECYSTITIS; CONTROLLED STUDY; FEMALE; GALLBLADDER CARCINOMA; GALLSTONE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA; AGED; CARCINOMA; CARCINOMA, ADENOSQUAMOUS; CELL TRANSFORMATION, NEOPLASTIC; CHOLECYSTECTOMY; CHOLECYSTITIS; CHRONIC DISEASE; DNA MUTATIONAL ANALYSIS; FEMALE; GALLBLADDER; GALLBLADDER NEOPLASMS; GALLSTONES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REFERENCE VALUES; RISK FACTORS; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 3342911408     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Sumiyoshi K, Nagai E, Chijiiwa F: Pathology of carcinoma of the gallbladder. World J Surg 1991; 15:315-321.
2. Ouchi K, Matsuno S, Sato T: Long-term survival in carcinoma of the biliary tract. Analysis of prognostic factors in 146 resections. Arch Surg 1989; 124:248-252.
3. Henson DE, Albores-Saavedra J, Corle D: Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates. Cancer 1992; 70(6):1493-197.
4. Tazuma S, Kajiyama G: Carcinogenesis of malignant lesion of the gallbladder. Langenbeck's Arch Surg 2001; 386(3):224-229.
5. Nakayama F: Recent progress in the diagnosis and treatment of carcinoma of the gallbladder. World J Surg 1991; 15:313-314.
6. Bhaskaran V: Hormonal receptors in carcinoma of the gallbladder. Trop Gastroenterol 2000; 21(2):48-50.
7. Barbosa-Coutinho LM, Arnt RA, Rocha JL, Ossanai R: Carcinoma de vesicula biliar: estudo de 26 casos. Rev. AMRIGS 1992: 36(1):9-14.
8. Cunha JE, Penteado S, Jukemura J: Neoplasias da Vesicula biliar. In: Kalil AN, Coelho J, Strauss E (Eds.). Figado e Vias Biliares-Clinica e Cirurgia. Rio de Janeiro: Editora Revinter R Ltda, 2001; pp.650-657.
9. Pandey M, Pathak AK, Amitabh G: Carcinoma of the gallbladder. A retrospective review of 99 cases. Dig Dis Sci 2001; 46(6):1145-1151.
10. Nigro AJT, Pugliesi JrWJ, Wechi SL, et al: Câncer da vesícula biliar. Ann Paul Med Cir 1978; 105:63-70.
11. Monteiro MC: Cancer da vesícula biliar. Análise de 100 casos operados. Arq Bras Med 1985; 59:337-344.
12. Ziliotto JA, Kunzle JE, Sgarbi EC: Carcinoma primário de vesícula biliar. Rev Bras Cancerol 1985; 31:103-106.
13. Kaushik SP: Current perspectives in gallbladder carcinoma: J Gastroenterol Hepatol 2001; 16(8):848-854.
14. Aretxabala X, Roa I, Burgos L, et al: Gallbladder cancer in Chile. A report on 54 potentially resectable tumors. Cancer 1992; 69(1):60-65.
15. Strom BL, Soloway RD, Rios-Dalenz JL, et al: Risk factors for gallbladder cancer. An International collaborative case-control study. Cancer 1995; 76(10):1747-1756.
16. Sheth S, Bedford A, Chopra S: Primary gallbladder cancer: recognition of risk factors and role of prophylatic cholecystectomy. Am J Gastroenterol 2000; 95(6):1402-1410.
17. Brumini R, Torloni H, Henson DE, Gotieb SLD, Souza JMP: Câncer no Brasil - Dados Histopatológicos - 1976-1980, Rio de Janeiro, Ministério da Saúde 1982.
18. Wistuba II, Gazdar AF, Roa I, et al: P53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study. Hum Pathol 1996; 27(4):360-365.
19. Wistuba II, Sugio K, Hung J, et al: Allele specific mutations involved in the pathogenesis of endemic galllbladder carcinoma in Chile. Cancer Res 1995; 55:2511-2515.
20. Kamel D, Paakko P, Nuorva K, et al: P53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder. J Pathol 1993; 170:67-72.
21. Teh M, Wee A, Path MCR, et al: An immunohistochemical study of p53 protein in gallbladder and extrehepatic bile duct/ampullary carcinomas. Cancer 1994; 74(5):142-145.
22. Greenblatt MS, Bennet WT, Hollstein M, et al: Mutations in the p53 tumor supressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54:4855-4878.
23. Tobias ES, Black DM: The Molecular biology of cancer. In: Rimon DL, Connor JM, Pyeritz RE, Korf BR (Eds.). In Principles of Medical Genetics. 4th Edition. London: Harcourt Publishers Limited, 2002; pp. 533-537.
24. Fujii K, Yokozaki H, Yasui W, et al: High frequency of p53 gene mutation in adenocarcinomas of the gallbladder. Cancer Epidemiol Biomarkers Prevent 1996; 5:461-466.
25. Yamaguchi A, Kurosaka Y, fushida S, et al: Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis. Cancer 1992; 70:2778-2784.
26. Walker RA, Dearing SJ, Lane DP, et al: Expression of p53 protein in infiltrating and in situ breast carcinomas. J Pathol 1991; 165:203-211.
27. Iggo R, Gatter K, Bartek J, et al: Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990; 335:675-679.
28. Sasano H, Miyazaki S, GoouKon Y, et al: Expression of p53 in human esophageal carcinoma: an immunohistochemical study with correlation to proliferating cell nuclear antigen expression. Hum Pathol 1992; 23:1238-1243.
29. Itoi T, Watanabe H, Yoshida M, et al: Correlation of p53 protein expression with gene mutation in gallbladder carcinomas. Pathol Int 1997; 47(8):525-530.
30. Kim YW, Huh SH, Park YK, et al: Expression of the c-erb-B2 and p53 protein in gallbladder carcinomas. Oncol Rep 2001; 8(5):1127-1132.
31. Wee A, Teh M, Raju GC: Clinical importance of p53 protein in gallbladder carcinoma and its precursor lesions. J Clin Pathol 1994; 47:453-456.
32. Oohashi Y, Watanabe H, Ajioka Y, et al: P53 Immunostaining distinguishes malignant from benign lesions of the gall-bladder. Pathol Int 1995; 45(1):58-65.
33. Diamantis I, Karamitopoulou E, Perentes E, et al: P53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: correlation with tumor grade and survival. Hepatology 1995; 22(3):774-779.
34. Roa I, Villaseca M, Araya J, et al: P53 tumor suppressor gene protein expression in early and advanced gallbladder carcinoma. Histopathology 1997; 31:226-230.
35. Ajiki T, Onoyama H, Yamamoto M, et al: P53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions. Hepatogastroenterology 1996; 43:521-526.
36. Washington K, Gottfried MR: Expression of p53 in adenocarcinoma of the gallbladder and bile ducts. Liver 1996; 16:99-104.
37. Misra S, Chatuverdi A, Goel MM, et al: Overexpression of p53 protein in gallbladder carcinoma in North India. Eur J Surg Oncol 2000; 26:164-167.
38. Quan ZW, Wu K, Wang J, et al: Association of p53, p16, and vascular endothelial growth factor protein expressions with the prognosis and metastasis of gallbladder cancer. J Am Coll Surg 2001; 193(4):380-383.
39. Nevin JE, Moran TJ, Kay S, et al: Carcinoma of the gallbladder: staging, treatment and diagnosis. Cancer 1976; 37:141-148.
40. Albores-Saavedra J, Henson DE, Sobin LH: The WHO Histological Classification of Tumors of the Gallbladder and Extrahepatic Bile Ducts. A comentary on the second edition. Cancer 1992; 70(2):410-414.
41. Sato T, Koyama K, Yamaguchi H, et al: Early carcinoma of gallbladder. Gastroenterol Jpn 1981; 16:459-464.
42. Jukemura J: Câncer de vesícula biliar. In: Gayotto LCC, Alves VAF (Eds.). Doenças do Figado e Vias Biliares. Sao Paulo: Editora Atheneu, 2001; pp. 1039-1047.
43. Yanagisawa N, Mikami T, Koike, Okayasu I: Enhanced cell kinetics, p53 accumulation and high p21 expression in chronic cholecystitis: comparison with background mucosa of gallbladder carcinomas. Histopathology 2000; 36(1):54-61.
44. Lazcano-Ponce EC, Miquel JF, Muñoz N, et al: Epidemiology and molecular pathology of gallbladder cancer. Cancer J Clin 2001; 51:349-364.
45. Jorde LB, Carey JC: Genetica do cancer. In: Jorde LB, Carey JC, Bamshad MJ, White RL (Eds.). Genética Médica. 2nd Edition. Rio de Janeiro: Editora Guanabara Koogan, 2000; pp. 197-212.